Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Investigator/Firm Financial Ties May Trigger Heavier Scrutiny Of Data By FDA

Executive Summary

Disclosure of financial arrangements between a clinical investigator and study sponsor will lead to a more stringent product review at FDA, Office of Drug Evaluation I Associate Director-Regulatory Affairs Linda Carter told the Food & Drug Law Institute.

You may also be interested in...



Scotia Foscan NDA Amendment Could Get Treatment Benefit In Labeling

An efficacy amendment to Scotia's Foscan NDA may allow the company to detail a treatment benefit in labeling for the head and neck cancer palliative agent, the firm indicated.

Scotia Foscan NDA Amendment Could Get Treatment Benefit In Labeling

An efficacy amendment to Scotia's Foscan NDA may allow the company to detail a treatment benefit in labeling for the head and neck cancer palliative agent, the firm indicated.

CRO Role In Clinical Trial Research Questioned By NEJM Article

The increasing use of contract research organizations in the clinical trial process could increase skepticism among physicians and the public about study results, a New England Journal of Medicine "Health Policy Report" maintains.

Related Content

UsernamePublicRestriction

Register

PS036171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel